The country research report on China gene therapy market is a customer intelligence and competitive study of the China market.
Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the China market. Also, factors that are driving and restraining the gene therapy market are highlighted in the study. This is an in-depth business intelligence report based on qualitative and quantitative parameters of the market. Additionally, this report provides readers with market insights and detailed analysis of market segments to possible micro levels. The companies and dealers/distributors profiled in the report include manufacturers & suppliers of gene therapy market in China.
The report on China gene therapy market provides a detailed analysis of segments in the market based on type, applications, and vector type.
Segmentation based on Type • Suicide Gene Therapy • Cancer Gene Therapy • Tumor Suppressor Gene Therapy • Cytokine Gene Therapy • Antigen Gene Therapy • Others
Segmentation based on Vector Type • Non-viral Vectors • Viral Vectors
Highlights of the report The report provides detailed insights into: 1) Demand and supply conditions of gene therapy market 2) Factor affecting the gene therapy market in the short run and the long run 3) The dynamics including drivers, restraints, opportunities, political, socioeconomic factors, and technological factors 4) Key trends and future prospects 5) Leading companies operating in gene therapy market and their competitive position in China 6) The dealers/distributors profiles provide basic information of top 10 dealers & distributors operating in (China) gene therapy market 7) IGR Matrix: to position the product types 8) Market estimates up to 2024
The report answers questions such as: 1) What is the market size of gene therapy market in China? 2) What are the factors that affect the growth in gene therapy market over the forecast period? 3) What is the competitive position in China gene therapy market? 4) What are the opportunities in China gene therapy market? 5) What are the modes of entering China gene therapy market?
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Cell and Gene Therapy Market Report The global cell and gene therapy market by revenue is expected to grow at a CAGR of over 30.90% during the period 2019–2025. The global cell and gene therapy market is one of the fastest-growing segments...
200 pages •
By The Business Research Company
• Jul 2020
Major players in the viral vectors & plasmid DNA market are FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, ??n?k? ??r??r?t??n, Cell and Gene Therapy Catapult, VGXI, and MassBiologics. The global viral vectors & plasmid DNA market is expected to grow from...
This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.
Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type (Adeno-Associated Virus, Adenovirus, Lentivirus, and Plasmid DNA), by Indication (Cancer, Genetic Disorder, and Infectious Disease), by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Viral Vector &...
Gene Therapy Market Research Report by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy, Suicide Gene Therapy, and Tumor Suppressor Gene Therapy), by Vector Type (Non-viral Vectors and Viral Vectors), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Gene Therapy...
The global viral vector & plasmid DNA manufacturing market is expected to reach US$ US$ 2,247.7 million by 2027 from US$ 459.4 million in 2019. The market is estimated to grow with a CAGR of 22.1% from 2020 to 2027. Driving factors such as growing awareness of gene therapy, increasing prevalence of genetic disorders and infectious diseases...
The Global Gene Therapy Partnering Agreements 2014-2020 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.